Display Settings:

Format

Send to:

Choose Destination
Leuk Res. 2006 Jan;30(1):103-5. Epub 2005 Jun 24.

Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin.

Author information

  • 1Department of Leukemia, Box 428, University of Texas-M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. fravandi@mdanderson.org

Abstract

Treatment of adult T-cell leukemia (ATL) remains difficult. Alemtuzumab with or without nucleoside analogs such as pentostatin may provide a role in this setting. However, the associated immunosuppression is a concern in patients with viral-mediated disease.

PMID:
15979704
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk